We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+10.91%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$470B
AUM Growth
+$74.8B
Cap. Flow
+$24.4B
Cap. Flow %
5.19%
Top 10 Hldgs %
30.35%
Holding
14,310
New
2,075
Increased
5,756
Reduced
4,471
Closed
1,856

Sector Composition

Rank Sector Weight
1 Technology 2.31%
2 Consumer Discretionary 1.61%
3 Financials 1.35%
4 Healthcare 1.15%
5 Communication Services 0.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRKR icon
12101
Marker Therapeutics
MRKR
$25.3M
$12.5K ﹤0.01%
+17,606
New +$41.9K
TFFP
12102
CALL
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$12.4K ﹤0.01%
720
+240
+50% +$5.2K
WEJO
12103
DELISTED
Wejo Group Limited Common Shares
WEJO
$12.4K ﹤0.01%
25,095
-82,509
-77% -$51.6K
VTVT icon
12104
vTv Therapeutics
VTVT
$134M
$12.3K ﹤0.01%
+382
New +$13K
IMDX
12105
Insight Molecular Diagnostics
IMDX
$145M
$12.3K ﹤0.01%
1,739
-1,541
-47% -$11.4K
CISO
12106
CALL
CISO Global
CISO
$10.2M
$12.3K ﹤0.01%
2,407
-800
-25% -$13K
LNAI
12107
Lunai Bioworks
LNAI
$9.97M
$12.3K ﹤0.01%
+168
New +$14.8K
DOYU
12108
CALL
DouYu International Holdings
DOYU
$128M
$12.3K ﹤0.01%
+1,030
New +$15.3K
SBFMW
12109
Sunshine Biopharma Inc Warrant
SBFMW
$124K
$12.2K ﹤0.01%
24,456
-14,753
-38% -$7.7K
BRNX
12110
BrenX
BRNX
$4.01M
$12.2K ﹤0.01%
1
GYRE icon
12111
Gyre Therapeutics
GYRE
$708M
$12.1K ﹤0.01%
+3,883
New +$14.8K
NRXP icon
12112
CALL
NRX Pharmaceuticals
NRXP
$159M
$12K ﹤0.01%
1,820
-1,300
-42% -$13.2K
UAMY icon
12113
United States Antimony
UAMY
$778M
$11.9K ﹤0.01%
31,424
-67,286
-68% -$27.6K
VIVO
12114
VivoPower PLC
VIVO
$128M
$11.8K ﹤0.01%
2,672
-69
-3% -$335
CGEN icon
12115
Compugen
CGEN
$272M
$11.7K ﹤0.01%
16,700
+17
+0.1% +$14
IMV
12116
CALL
DELISTED
IMV Inc. Common Shares
IMV
$11.7K ﹤0.01%
+21,700
New +$32.4K
STKH
12117
Steakholder Foods
STKH
$3.54M
$11.7K ﹤0.01%
+13
New +$14K
NKTR icon
12118
CALL
Nektar Therapeutics
NKTR
$2.56B
$11.6K ﹤0.01%
+1,107
New +$33.5K
VYNT
12119
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$11.6K ﹤0.01%
+20,001
New +$15.9K
FTK icon
12120
Flotek Industries
FTK
$869M
$11.6K ﹤0.01%
2,792
-11,877
-81% -$78.1K
OTRK
12121
DELISTED
Ontrak
OTRK
$11.5K ﹤0.01%
242
+11
+5% +$697
CANG
12122
Cango Inc
CANG
$97.6M
$11.4K ﹤0.01%
1,002
-528
-35% -$6.99K
TMPO
12123
DELISTED
Tempo Automation Holdings, Inc. Common Stock
TMPO
$11.4K ﹤0.01%
+14,038
New +$17.3K
CTHR
12124
DELISTED
Charles & Colvard Ltd
CTHR
$11.3K ﹤0.01%
1,218
-176
-13% -$1.6K
OCG icon
12125
Oriental Culture Holding
OCG
$3.04M
$11.3K ﹤0.01%
8
-8
-50% -$16.1K

Similar funds

Jeff Yass's Q1 2023 Portfolio in Review

As of Q1 2023, Jeff Yass held 14,310 positions worth $470B, up 19% from $395B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Jeff Yass deployed $24.4B of net new capital in Q1 2023, opening 2,075 new positions and adding to 5,756 existing holdings. Its largest new stake was Schwab US Aggregate Bond ETF: 2,949,950 shares worth $69.2M.

By sector, the portfolio is most concentrated in Technology at 2.3% of assets, up from 2.1% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Tesla, an estimated $1.62B trimmed.

  • Jeff Yass's largest Q1 2023 buy was Schwab US Aggregate Bond ETF: 2,949,950 shares worth $69.2M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $1.22B increase.
  • Jeff Yass's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.62B.
  • Jeff Yass fully exited NextEra Energy, Inc. 5.279% Corporate Units in Q1 2023, selling an estimated $61.5M.
  • Jeff Yass's ten largest holdings make up 30% of its $470B portfolio in Q1 2023.
  • Jeff Yass opened 2,075 new positions and closed 1,856 in Q1 2023.
  • Jeff Yass's portfolio value rose 19% quarter-over-quarter to $470B.

Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.